BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11371615)

  • 1. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.
    Yang X; Su K; Roos MD; Chang Q; Paterson AJ; Kudlow JE
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6611-6. PubMed ID: 11371615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1.
    Lim K; Chang HI
    FEBS Lett; 2009 Feb; 583(3):512-20. PubMed ID: 19070619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y.
    Lim K; Chang HI
    Biochem Biophys Res Commun; 2009 May; 382(3):593-7. PubMed ID: 19302979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modification by O-GlcNAc: another way to change protein function.
    Kudlow JE
    J Cell Biochem; 2006 Aug; 98(5):1062-75. PubMed ID: 16598783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon.
    Majumdar G; Harmon A; Candelaria R; Martinez-Hernandez A; Raghow R; Solomon SS
    Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E584-91. PubMed ID: 12900380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
    Chung SS; Kim JH; Park HS; Choi HH; Lee KW; Cho YM; Lee HK; Park KS
    Biochem Biophys Res Commun; 2008 Aug; 372(4):713-8. PubMed ID: 18513490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc inhibits interaction between Sp1 and Elf-1 transcription factors.
    Lim K; Chang HI
    Biochem Biophys Res Commun; 2009 Mar; 380(3):569-74. PubMed ID: 19285002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1.
    Lim KH; Chang HI
    FEBS Lett; 2006 Aug; 580(19):4645-52. PubMed ID: 16879824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc inhibits interaction between Sp1 and sterol regulatory element binding protein 2.
    Lim K; Chang HI
    Biochem Biophys Res Commun; 2010 Mar; 393(2):314-8. PubMed ID: 20138838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
    Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
    Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated O-linked N-acetylglucosamine correlated with reduced Sp1 cooperative DNA binding with its collaborating factors in vivo.
    Lim K; Chang HI
    Biosci Biotechnol Biochem; 2010; 74(8):1668-72. PubMed ID: 20699577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor.
    Kommaddi RP; Dickson KM; Barker PA
    J Neurochem; 2011 Feb; 116(3):396-405. PubMed ID: 21105874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins.
    Roos MD; Xie W; Su K; Clark JA; Yang X; Chin E; Paterson AJ; Kudlow JE
    Proc Assoc Am Physicians; 1998; 110(5):422-32. PubMed ID: 9756093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
    Walgren JL; Vincent TS; Schey KL; Buse MG
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E424-34. PubMed ID: 12397027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells.
    Donadio AC; Lobo C; Tosina M; de la Rosa V; Martín-Rufián M; Campos-Sandoval JA; Matés JM; Márquez J; Alonso FJ; Segura JA
    J Cell Biochem; 2008 Feb; 103(3):800-11. PubMed ID: 17614351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-Linked N-acetylglucosaminylation of Sp1 interferes with Sp1 activation of glycolytic genes.
    Lim K; Yoon BH; Ha CH
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):349-53. PubMed ID: 26499076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation.
    Lamarre-Vincent N; Hsieh-Wilson LC
    J Am Chem Soc; 2003 Jun; 125(22):6612-3. PubMed ID: 12769553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of O-linked GlcNAc modification on the glucose response of ChREBP.
    Sakiyama H; Fujiwara N; Noguchi T; Eguchi H; Yoshihara D; Uyeda K; Suzuki K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):784-9. PubMed ID: 21036147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of topoisomerase I activity by glucose and by O-GlcNAcylation of the enzyme protein.
    Noach N; Segev Y; Levi I; Segal S; Priel E
    Glycobiology; 2007 Dec; 17(12):1357-64. PubMed ID: 17932134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.